How well does a new bevacizumab medication work for advanced colorectal cancer

This study is following patients with advanced colorectal cancer who are receiving Elovie, a bevacizumab medication used to treat this disease. Researchers want to collect information about how well this medication works and how safe it is in everyday clinical practice across cancer centers in Brazil. This is called a real-world study because it looks at actual patient care rather than testing in a controlled lab setting.

While this medication has been approved for use, researchers want to understand how it performs in real patients and real treatment settings. By gathering data from many cancer centers, they can learn whether the treatment is working as expected and identify any safety concerns that might not have shown up in earlier trials.